or
Sign in to turn on 1-Click ordering.
or
Amazon Prime Free Trial required. Sign up when you check out. Learn More
More Buying Choices
Have one to sell? Sell yours here
Exploiting Chemical Diversity for Drug Discovery (Biomolecular Sciences Series) (RSC Biomolecular Sciences)
 
See larger image
 
Tell the Publisher!
I'd like to read this book on Kindle

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

Exploiting Chemical Diversity for Drug Discovery (Biomolecular Sciences Series) (RSC Biomolecular Sciences) [Hardcover]

Paul A. Bartlett (Editor), Michael Entzeroth (Editor)

Price: $244.00 & this item ships for FREE with Super Saver Shipping. Details
  Special Offers Available
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
In Stock.
Ships from and sold by Amazon.com. Gift-wrap available.
Only 1 left in stock--order soon (more on the way).
Want it delivered Monday, January 30? Choose One-Day Shipping at checkout. Details
Textbook Student FREE Two-Day Shipping for Students. Learn more


Book Description

0854048421 978-0854048427 April 1, 2006 1
Conceptual and technological advances in chemistry and biology have transformed the drug discovery process. Evolutionary pressure among the diverse scientific and engineering disciplines that contribute to the identification of biologically active compounds has resulted in synergistic improvements at every step in the process. Exploiting Chemical Diversity for Drug Discovery encompasses the many components of this transformation and presents the current state-of-the-art of this critical endeavour. From the theoretical and operational considerations in generating a collection of compounds to screen, to the design and implementation of high-capacity and high-quality assays, this book provides a comprehensive overview of modern approaches to lead identification.

Special Offers and Product Promotions

  • Buy $50 in qualifying physical textbooks, get $5 in Amazon MP3 Credit. Here's how (restrictions apply)

Editorial Reviews

Review

Maximising Drug Hits

Exploiting chemical diversity for drug discovery

Entzeroth, M., Bartlett , P. A.
Cambridge, UK: Royal Society of Chemistry, 2006, 345pp, ISBN 978-0-85404-842-7

 

 

Reviewed by Christopher Newton

This book is authored by 39 contributors and reviews the contemporary hit discovery process. Surveyed are the sources of chemicals for screening – particularly how large numbers of compounds can be acquired efficiently – and how the biological attributes of those compounds can be generated in both cost- and time-efficient ways. 

Modern chemical techniques that reduce the costly need to purify synthetic arrays of molecules are presented to the reader in the early chapters (solid-phase reagents, microwaves, sonochemistry and fluorous chemistry). Less familiar territory covers the production of molecules for screening by genetically altering enzymes that produce compound classes like polyketides, or by diversifying from natural product scaffolds. The book is, however, typical of its era and largely ignores new natural products as sources of new hits.  

The book provides useful comparisons of commercial sources of compounds. For organisations wedded to the requirement to obtain molecules with ‘diversity’, introductions to this concept are given, and indeed for the computational diversity specialist, mathematical tools are derived. For organisations more interested in acquiring molecules likely to interact with genomic classes, the derivation of such molecules is usefully reviewed. For the generalist, the characteristics of drug-likeness – the fraction of the chemical universe likely to give exposure after oral administration – is well covered. 

The remaining nine chapters of the book deal with processing molecules to generate biological data. Included are the technical problems of handling very small volumes of liquids so that reproducible biological results can be generated. Technologies for screening are reviewed across the chapters; some get a chapter to themselves (fluorescence screening, NMR screening). Assessment of molecules in vitro and in silico for in vivo pharmacokinetics and liabilities is reviewed, and the later hit and lead optimisation phase of in-depth compound characterisation by high-content screening is also surveyed. 

I am currently responsible for the chemical and biological operations of a company that generates large numbers of compounds and their associated biological data for clients worldwide, and I thought that this book might be a useful companion for an 11 hour trip to Japan. The anticipation was largely rewarded, as the authors give sensible, contemporary views of the issues surrounding generating and testing large numbers of compounds in the hit-finding process. 

Chemistry World 2006, 3(3), p.p.68


Product Details


Customer Reviews


There are no customer reviews yet.
Video reviews
Video reviews
Amazon now allows customers to upload product video reviews. Use a webcam or video camera to record and upload reviews to Amazon.



Tag this product

 (What's this?)
Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items.
Your tags: Add your first tag
 

Sell a Digital Version of This Book in the Kindle Store

If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store. Learn more

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums


Listmania!


Create a Listmania! list

So You'd Like to...


Create a guide


Look for Similar Items by Category


Look for Similar Items by Subject